Cardiopulmonary bypass (CPB) is a unique clinical scenario that results in widespread
activation of the hemostatic system. However, surgery also results in normal increases in …

THE INCIDENCE of congenital heart defects is approx-imately 7 to 10 per 1,000 live births. 1
With advancing technology and improved diagnostic, surgical, anesthetic, and postoperative …

This study was to compare the impact of different biocompatible coated circuits on
inflammatory response and oxidative stress induced during cardiopulmonary bypass (CPB) …

Blood clots when it contacts foreign surfaces following platelet activation. This can be
catastrophic in clinical settings involving extracorporeal circulation such as during heart …

Coronavirus disease 2019 (COVID-19) is a serious health concern which affects all
healthcare professionals worldwide. The pandemic puts health services, including cardiac …

Attenuated inflammatory response and decreased platelet activation have been claimed
repeatedly when biocompatible circuits are used for cardiopulmonary bypass. We evaluated …

The COVID-19 pandemic puts health services, including cardiac surgery units, under
escalating pressure. The Heart Team is confronted with a novel virus and disease which …

Objective. A manifestation of inflammatory injury to the heart, atrial fibrillation (AF), ranks
among the most frequent and potentially life-threatening post-operative complications …

This chapter covers management of pediatric cardiopulmonary bypass (CPB). First, it is
compared with the procedure in adults, then the physiology is discussed in detail …

This prospective randomized study compares novel hyaluronan-based heparin-bonded
circuits vs. uncoated controls across EuroSCORE patient risk strata including biomaterial …